Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Galectins in kidney development.

R Colin Hughes1

  • 1National Institute for Medical Research, Mill Hill, London NW7 1AA, UK. colin.hughes@nimr.mrc.ac.uk

Glycoconjugate Journal
|February 6, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Roger W. Jeanloz.

Advances in carbohydrate chemistry and biochemistry·2010
Same author

In memory of Roger W. Jeanloz, a pioneer glycobiologist (1917-2007).

Glycobiology·2008
Same author

Galectin-3 associates with the primary cilium and modulates cyst growth in congenital polycystic kidney disease.

The American journal of pathology·2006
Same author

Specificity of interactions of galectin-3 with Chrp, a cysteine- and histidine-rich cytoplasmic protein.

Biochimie·2003
Same author

Galectin-3 modulates ureteric bud branching in organ culture of the developing mouse kidney.

Journal of the American Society of Nephrology : JASN·2001
Same journal

Correction to: Alpha-Gal syndrome unveiled: decoding the glycan-driven red meat allergy.

Glycoconjugate journal·2026
Same journal

Mechanistic and functional integration of sirtuin deacylases: from substrate specificity to biological outcomes.

Glycoconjugate journal·2026
Same journal

Macrophage modulation accounts for the anti-inflammatory effect of Hypnea cervicornis agglutinin in rat arthritis induced by zymosan.

Glycoconjugate journal·2026
Same journal

Nucleolar-localized sialidase Neu4 suppresses cell proliferation through destabilizing c-Myc via interacting with ribosomal proteins L5 and L11.

Glycoconjugate journal·2026
Same journal

3'-sialyllactose inhibits the migration and invasion of LPS-induced B16F10 mouse melanoma cells through inactivation of the NF-<sub>K</sub>B signaling pathway.

Glycoconjugate journal·2026
Same journal

Mechanism analysis of transgene expression induced by chitosan/hyaluronic acid nanoparticles in CD44v9/RHAMM co-expressed gastric cancer cells: contribution of hyaluronic acid to RHAMM-mediated intracellular transport.

Glycoconjugate journal·2026
See all related articles

Galectins are proteins involved in tissue organization. This review explores their roles in normal kidney development and links their abnormal expression to kidney disease.

Area of Science:

  • Biochemistry
  • Developmental Biology
  • Nephrology

Background:

  • Galectins are a protein family with diverse carbohydrate-binding specificities, cell-type distributions, and functions.
  • Extracellular galectins influence cellular adhesion and signaling pathways crucial for tissue organization.
  • These processes are vital for normal tissue development and maintenance.

Purpose of the Study:

  • To review recent advancements in understanding galectin roles during kidney development.
  • To discuss the association between aberrant galectin expression and kidney disease pathogenesis.

Main Methods:

  • Literature review of studies on galectin expression and function in kidney development.
  • Analysis of evidence linking galectin dysregulation to kidney pathologies.

Related Experiment Videos

Main Results:

  • Galectins play significant roles in the establishment and maintenance of kidney tissue organization during normal development.
  • Altered expression patterns of specific galectins are implicated in various kidney diseases.

Conclusions:

  • Galectins are critical regulators of kidney development.
  • Aberrant galectin expression represents a potential biomarker and therapeutic target for kidney diseases.